Amend 004 - Hepatitis B Adult and Pediatric Vaccine - GlaxoSmithKline Inc.
Status Awarded
Contract number E60PH-22HEPB/001/PH
Solicitation number E60PH-22HEPB/A
Publication date
Contract award date
Last amendment date
Amendment value
Status Awarded
Contract number E60PH-22HEPB/001/PH
Solicitation number E60PH-22HEPB/A
Publication date
Contract award date
Last amendment date
Amendment value
This contract was awarded to:
The contract will be for a period of 36 month(s), from 2022/03/07 to 2025/03/31.
CAD 21,595,100.80